Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2012 by Essen Technology (Beijing) Co., Ltd.
Sponsor:
Information provided by (Responsible Party):
Essen Technology (Beijing) Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01681381
First received: September 5, 2012
Last updated: February 20, 2013
Last verified: November 2012